Quarterly Results- overall
Annual Results- Scale
Annual Results- Liquidity
Annual Results- Profitability/Return
Annual Results- Valuation
External Ecosystem
Sector
Major Subsidiaries/Associates
Key Clients
Products
Products
Product details
Operations
Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
|
RPG Life Reports Gross Margin Improvement Of 260 Basis Points Year Over Year
Read More
|
|
RPG Life Sciences Posts 16.5% Revenue Growth To ?211.6 Crore In Q2 FY27; Adjusted EBITDA Rises 15%
Read More
|
|
RPG Life Sciences Q2: net profit stands at ?28.2 Cr on 16.5% revenue growth; API subsidiary restructuring and acquisitions shape earnings
Read More
|
|
RPG Life Sciences Limited (RPGLIFE) share price — eduinvesting
Read More
|
|
RPG Life Sciences Reports Q2 Standalone Net Profit Of ?23.3 Crore Vs ?36.9 Crore YoY
Read More
|
|
RPG Life Sciences RPGLIFE Q2 FY27 Results Board Meeting
Read More
|
|
RPGLIFE: Acquisitions lifted Q2 revenue, while H1 profit eased year over year
Read More
|
|
RPGLIFE: H1 revenue rose 16.2%, API sales surged 58.5%, and market cap climbed 64%
Read More
|
|
Anti-cancer drug prices slashed for 543 brands; new MRPs effective from Nov 9
Read More
|
|
NPPA releases Revised MRP for 543 brands of Anti-Cancer Medicines; List to be updated on continual basis; New Prices Effective from November 9, 2026
Read More
|
|
NPPA revises MRP of 543 anti-cancer medicine brands; new prices effective from November 9
Read More
|